Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,003 public trials 2,033 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

eHealth for the Elderly

NCT04393090

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hämato-Onkologische Schwerpunktpraxis Aschaffenburg, Germany
  • Onkologie-Köln, Cologne, Germany
  • St.-Antonius-Hospital Eschweiler, Germany
  • Praxis am Albertinen- Krankenhaus Hamburg, Germany
View Trial Details
Completed

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

NCT01154816

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hepatoblastoma, +33 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 105 locations
View Trial Details
Completed

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

NCT02223052

Conditions
Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +106 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

NCT01081015

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • New Hope Cancer & Research Institute Pomona, California, United States
  • Medical Specialists of the Palm Beaches Atlantis, Florida, United States
  • University Cancer Institute Boynton Beach, Florida, United States
  • Thomas Niederman, MD Boynton Beach, Florida, United States
View all 165 locations
View Trial Details
Completed

Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)

NCT02322320

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego Medical Center La Jolla, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
View all 42 locations
View Trial Details

Related conditions